685 related articles for article (PubMed ID: 27549788)
1. Prevalence and factors associated with nontuberculous mycobacteria in non-cystic fibrosis bronchiectasis: a multicenter observational study.
Máiz L; Girón R; Olveira C; Vendrell M; Nieto R; Martínez-García MA
BMC Infect Dis; 2016 Aug; 16(1):437. PubMed ID: 27549788
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of methods for the isolation of nontuberculous mycobacteria from patients with cystic fibrosis, bronchiectasis and patients assessed for lung transplantation.
Stephenson D; Perry A; Appleby MR; Lee D; Davison J; Johnston A; Jones AL; Nelson A; Bourke SJ; Thomas MF; De Soyza A; Lordan JL; Lumb J; Robb AE; Samuel JR; Walton KE; Perry JD
BMC Pulm Med; 2019 Jan; 19(1):19. PubMed ID: 30665395
[TBL] [Abstract][Full Text] [Related]
3. Nontuberculous mycobacteria in diffuse panbronchiolitis.
Tsuji T; Tanaka E; Yasuda I; Nakatsuka Y; Kaji Y; Yasuda T; Hashimoto S; Hwang MH; Hajiro T; Taguchi Y
Respirology; 2015 Jan; 20(1):80-6. PubMed ID: 25269823
[TBL] [Abstract][Full Text] [Related]
4. Nontuberculous mycobacteria in bronchiectasis: Prevalence and patient characteristics.
Fowler SJ; French J; Screaton NJ; Foweraker J; Condliffe A; Haworth CS; Exley AR; Bilton D
Eur Respir J; 2006 Dec; 28(6):1204-10. PubMed ID: 16807259
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of Pulmonary Nontuberculous Mycobacterial Sputum Positivity in Patients with Cystic Fibrosis in the United States, 2010-2014.
Adjemian J; Olivier KN; Prevots DR
Ann Am Thorac Soc; 2018 Jul; 15(7):817-826. PubMed ID: 29897781
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with subsequent nontuberculous mycobacterial lung disease in patients with a single sputum isolate on initial examination.
Lee MR; Yang CY; Shu CC; Lin CK; Wen YF; Lee SW; Ko JC; Wang JY; Lee LN; Yu CJ
Clin Microbiol Infect; 2015 Mar; 21(3):250.e1-7. PubMed ID: 25658545
[TBL] [Abstract][Full Text] [Related]
7. Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis.
Mirsaeidi M; Hadid W; Ericsoussi B; Rodgers D; Sadikot RT
Int J Infect Dis; 2013 Nov; 17(11):e1000-4. PubMed ID: 23683809
[TBL] [Abstract][Full Text] [Related]
8. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis.
Olivier KN; Weber DJ; Wallace RJ; Faiz AR; Lee JH; Zhang Y; Brown-Elliot BA; Handler A; Wilson RW; Schechter MS; Edwards LJ; Chakraborti S; Knowles MR;
Am J Respir Crit Care Med; 2003 Mar; 167(6):828-34. PubMed ID: 12433668
[TBL] [Abstract][Full Text] [Related]
9. Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease.
Olivier KN; Weber DJ; Lee JH; Handler A; Tudor G; Molina PL; Tomashefski J; Knowles MR;
Am J Respir Crit Care Med; 2003 Mar; 167(6):835-40. PubMed ID: 12433669
[TBL] [Abstract][Full Text] [Related]
10. Nontuberculous mycobacteria in cystic fibrosis and non-cystic fibrosis bronchiectasis.
Park IK; Olivier KN
Semin Respir Crit Care Med; 2015 Apr; 36(2):217-24. PubMed ID: 25826589
[TBL] [Abstract][Full Text] [Related]
11. Safety and Effectiveness of Clofazimine for Primary and Refractory Nontuberculous Mycobacterial Infection.
Martiniano SL; Wagner BD; Levin A; Nick JA; Sagel SD; Daley CL
Chest; 2017 Oct; 152(4):800-809. PubMed ID: 28483608
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis.
Martiniano SL; Sontag MK; Daley CL; Nick JA; Sagel SD
Ann Am Thorac Soc; 2014 Jan; 11(1):36-44. PubMed ID: 24251858
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of RGM Medium for Isolation of Nontuberculous Mycobacteria from Respiratory Samples from Patients with Cystic Fibrosis in the United States.
Plongla R; Preece CL; Perry JD; Gilligan PH
J Clin Microbiol; 2017 May; 55(5):1469-1477. PubMed ID: 28228494
[TBL] [Abstract][Full Text] [Related]
14. Nontuberculous mycobacteria in cystic fibrosis patients on the Island of Gran Canaria. A population study.
Campos-Herrero MI; Chamizo FJ; Caminero JA; Gilarranz R; Cabrera G; Cuyás J
J Infect Chemother; 2016 Aug; 22(8):526-31. PubMed ID: 27262751
[TBL] [Abstract][Full Text] [Related]
15. Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin.
Coolen N; Morand P; Martin C; Hubert D; Kanaan R; Chapron J; Honoré I; Dusser D; Audureau E; Veziris N; Burgel PR
J Cyst Fibros; 2015 Sep; 14(5):594-9. PubMed ID: 25735458
[TBL] [Abstract][Full Text] [Related]
16. 'Lady Windermere's counterpart? Pulmonary nontuberculous mycobacteria in men with bronchiectasis.
Ku JH; Ranches G; Siegel SAR; Winthrop KL
Diagn Microbiol Infect Dis; 2020 Feb; 96(2):114916. PubMed ID: 31740173
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Various Culture Media for Detection of Rapidly Growing Mycobacteria from Patients with Cystic Fibrosis.
Preece CL; Wichelhaus TA; Perry A; Jones AL; Cummings SP; Perry JD; Hogardt M
J Clin Microbiol; 2016 Jul; 54(7):1797-1803. PubMed ID: 27098962
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors for a one-year improvement in nontuberculous mycobacterial pulmonary disease: An 11-year retrospective and multicenter study.
Cadelis G; Ducrot R; Bourdin A; Rastogi N
PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005841. PubMed ID: 28787454
[TBL] [Abstract][Full Text] [Related]
19. Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france.
Roux AL; Catherinot E; Ripoll F; Soismier N; Macheras E; Ravilly S; Bellis G; Vibet MA; Le Roux E; Lemonnier L; Gutierrez C; Vincent V; Fauroux B; Rottman M; Guillemot D; Gaillard JL;
J Clin Microbiol; 2009 Dec; 47(12):4124-8. PubMed ID: 19846643
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and importance of non-tuberculous mycobacteria in adult patients with cystic fibrosis in a hospital in Madrid.
Fernández-Caso B; Vázquez R; Alarcón T; Girón R; López-Giménez MR; Domingo D
Enferm Infecc Microbiol Clin (Engl Ed); 2020; 38(7):323-326. PubMed ID: 31744623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
